Literature DB >> 19320002

Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.

Melanie D Harrer1, Hans-Christian von Büdingen, Luc Stoppini, Chantal Alliod, Sandrine Pouly, Katja Fischer, Norbert Goebels.   

Abstract

Mononuclear cell infiltrates, deposits of immunoglobulin and complement as well as demyelination and axonal damage are neuropathological hallmarks of Multiple Sclerosis (MS) lesions. An involvement of antibodies is further suggested by the presence of oligoclonal immunoglobulins in the cerebrospinal fluid of almost all MS patients. However, which mechanisms are most relevant for de- and remyelination and axonal loss in MS lesions is poorly understood. To characterize the regenerative abilities of demyelinated CNS tissue, we utilized murine organotypic cerebellar slice cultures expressing GFP in oligodendrocytes. The addition of a demyelinating monoclonal antibody specific for myelin oligodendrocyte glycoprotein and complement induced complete myelin destruction and oligodendrocyte loss, as demonstrated by confocal live imaging and staining for different myelin proteins. After removal of antibodies and complement we visualized the stages of remyelination, presumably originating from proliferating oligodendrocyte precursor cells and guided by morphologically intact appearing axons. Allowing for the detailed live imaging of de- and remyelination in an ex vivo situation closely resembling the three dimensional cytoarchitecture of the CNS, we provide a useful experimental system for the evaluation of new therapeutic strategies to enhance remyelination and repair in MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320002     DOI: 10.1016/j.expneurol.2008.12.027

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Interactions between oligodendrocyte precursors control the onset of CNS myelination.

Authors:  Yan Yang; Rebecca Lewis; Robert H Miller
Journal:  Dev Biol       Date:  2010-12-07       Impact factor: 3.582

2.  Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.

Authors:  Bettina Sobottka; Melanie Denise Harrer; Urs Ziegler; Katja Fischer; Heinz Wiendl; Thomas Hünig; Burkhard Becher; Norbert Goebels
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

3.  Organotypic slice cultures to study oligodendrocyte dynamics and myelination.

Authors:  Robert A Hill; Jelena Medved; Kiran D Patel; Akiko Nishiyama
Journal:  J Vis Exp       Date:  2014-08-25       Impact factor: 1.355

4.  Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.

Authors:  Alessandra di Penta; Beatriz Moreno; Stephanie Reix; Begoña Fernandez-Diez; Maite Villanueva; Oihana Errea; Nagore Escala; Koen Vandenbroeck; Joan X Comella; Pablo Villoslada
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

Review 5.  Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.

Authors:  Patrick Peschl; Monika Bradl; Romana Höftberger; Thomas Berger; Markus Reindl
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

6.  Dose-dependent inhibition of demyelination and microglia activation by IVIG.

Authors:  Meike Winter; Christine Baksmeier; Julia Steckel; Sumanta Barman; Manish Malviya; Melanie Harrer-Kuster; Hans-Peter Hartung; Norbert Goebels
Journal:  Ann Clin Transl Neurol       Date:  2016-09-23       Impact factor: 4.511

Review 7.  Oligodendrocytes in Development, Myelin Generation and Beyond.

Authors:  Sarah Kuhn; Laura Gritti; Daniel Crooks; Yvonne Dombrowski
Journal:  Cells       Date:  2019-11-12       Impact factor: 6.600

8.  Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.

Authors:  Christine Baksmeier; Pat Blundell; Julia Steckel; Verena Schultz; Quan Gu; Ana Da Silva Filipe; Alain Kohl; Chris Linnington; Dongli Lu; Anne Dell; Stuart Haslam; Jiabin Wang; Dan Czajkowsky; Norbert Goebels; Richard J Pleass
Journal:  Immunology       Date:  2021-05-09       Impact factor: 7.215

9.  Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens.

Authors:  Stephanie C Joachim; Oliver W Gramlich; Panagiotis Laspas; Heiko Schmid; Sabine Beck; Harald D von Pein; H Burkhard Dick; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

10.  Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.

Authors:  Patrick Peschl; Kathrin Schanda; Bleranda Zeka; Katherine Given; Denise Böhm; Klemens Ruprecht; Albert Saiz; Andreas Lutterotti; Kevin Rostásy; Romana Höftberger; Thomas Berger; Wendy Macklin; Hans Lassmann; Monika Bradl; Jeffrey L Bennett; Markus Reindl
Journal:  J Neuroinflammation       Date:  2017-10-25       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.